Henn Matthew R.

Henn Matthew R. is listed in filings as See Remarks at Seres Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Seres Therapeutics, Inc. (MCRB). The current snapshot covers public activity from Aug 19, 2024 to May 19, 2026. Reported amounts are shown as $580 to $754. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.